{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:32:21Z","timestamp":1768883541497,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10147-018-1301-8","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T04:57:14Z","timestamp":1528174634000},"page":"989-998","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0672-9041","authenticated-orcid":false,"given":"Grace Hwei Ching","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claramae Shulyn","family":"Chia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sze Huey","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khee Chee","family":"Soo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa Ching Ching","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"issue":"2","key":"1301_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4251\/wjgo.v2.i2.102","volume":"2","author":"A Fagotti","year":"2010","unstructured":"Fagotti A, Gallotta V, Romano F et al (2010) Peritoneal carcinosis of ovarian origin. World J Gastrointest Oncol 2(2):102\u2013108. \n                    https:\/\/doi.org\/10.4251\/wjgo.v2.i2.102","journal-title":"World J Gastrointest Oncol"},{"issue":"5","key":"1301_CR2","first-page":"430","volume":"40","author":"CF Castillo del","year":"1993","unstructured":"del Castillo CF, Warshaw L (1993) Peritoneal metastases in pancreatic carcinoma. Hepatogastroenterology 40(5):430\u2013432","journal-title":"Hepatogastroenterology"},{"issue":"4","key":"1301_CR3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/00000658-197904000-00027","volume":"189","author":"JP Welch","year":"1979","unstructured":"Welch JP, Donaldson GA (1979) The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 189(4):496\u2013502","journal-title":"Ann Surg"},{"issue":"2","key":"1301_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O et al (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88(2):358\u2013363","journal-title":"Cancer"},{"issue":"3","key":"1301_CR5","doi-asserted-by":"publisher","first-page":"e266-e275","DOI":"10.3747\/co.23.2831","volume":"23","author":"J Spiliotis","year":"2016","unstructured":"Spiliotis J, Halkia E, de Bree E (2016) Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy\u2014current perspectives. Curr Oncol 23(3):e266-e275","journal-title":"Curr Oncol"},{"key":"1301_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-1-4613-1245-1_13","volume":"81","author":"PH Sugarbaker","year":"1996","unstructured":"Sugarbaker PH (1996) Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy. Cancer Treat Res 81:149\u2013168","journal-title":"Cancer Treat Res"},{"key":"1301_CR7","first-page":"39","volume":"169","author":"E Bree de","year":"2007","unstructured":"de Bree E, Tsiftsis DD (2007) Principles of perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis. Recent Results Cancer Res 169:39\u201351","journal-title":"Recent Results Cancer Res"},{"key":"1301_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","volume":"7","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker PH (2006) New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7:69\u201376","journal-title":"Lancet Oncol"},{"key":"1301_CR9","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","volume":"49","author":"D Baratti","year":"2013","unstructured":"Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M (2013) Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (hipec). Eur J Cancer 49:3140\u20133148","journal-title":"Eur J Cancer"},{"key":"1301_CR10","unstructured":"National Comprehensive Cancer Network (NCCN) (2016) Clinical Practice Guidelines in Oncology. Colon cancer. (v2.2016) March 14 2018. \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf"},{"key":"1301_CR11","unstructured":"National Institute for Health and Care Excellence (NICE) (2010) Cytoreduction surgery followed by hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis. (IPG 331), Feb 2010. \n                    https:\/\/www.nice.org.uk\/guidance\/ipg331\/documents\/cytoreduction-surgery-followed-by-hyperthermic-intraoperative-peritoneal-chemotherapy-for-peritoneal-carcinomatosis-interventional-procedures-consultation"},{"key":"1301_CR12","doi-asserted-by":"crossref","first-page":"iii1iii9","DOI":"10.1093\/annonc\/mdu438.11","volume":"25","author":"E Cutsem Van","year":"2014","unstructured":"Van Cutsem E, Cervantes A, Nordlinger B, Arnold D, on behalf of the ESMO Guidelines Working Group (2014) Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25 (suppl_3):iii1\u2013iii9","journal-title":"Ann Oncol"},{"issue":"3","key":"1301_CR13","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/02656736.2016.1262064","volume":"33","author":"G Tan","year":"2017","unstructured":"Tan G, Chia C, Kumar M et al (2017) 201 consecutive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in a single Asian tertiary centre. Int J of Hyperthermia 33(3):288\u2013294","journal-title":"Int J of Hyperthermia"},{"key":"1301_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29\u201342","journal-title":"Ann Surg"},{"key":"1301_CR15","first-page":"233","volume":"30","author":"PH Sugarbaker","year":"1997","unstructured":"Sugarbaker PH, Ronnett BM, Archer A et al (1997) Pseudomyxoma peritonei syndrome. Adv Surg 30:233\u2013280","journal-title":"Adv Surg"},{"key":"1301_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/00000658-199502000-00002","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH, Jablonsky KA (1995) Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221:124\u2013132","journal-title":"Ann Surg"},{"key":"1301_CR17","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1007\/s002800051093","volume":"43","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH (1999) Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 43:S15\u2013S25","journal-title":"Cancer Chemother Pharmacol"},{"key":"1301_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jso.21057","volume":"98","author":"R Younan","year":"2008","unstructured":"Younan R, Kusamura S, Baratti D et al (2008) Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J Surg Oncol 98:253\u2013257","journal-title":"J Surg Oncol"},{"issue":"10","key":"1301_CR19","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.ejso.2015.05.018","volume":"41","author":"TR Oudheusden van","year":"2015","unstructured":"van Oudheusden TR, Nienhuijs SW, Luyer MD et al (2015) Incidence and treatment of recurrent disease after cytoreductive surgery and intraperitoneal chemotherapy for peritoneally metastasized colorectal cancer: a systematic review. EJSO 41(10):1269\u20131277","journal-title":"EJSO"},{"issue":"10","key":"1301_CR20","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/annonc\/mdq762","volume":"22","author":"YLB Klaver","year":"2011","unstructured":"Klaver YLB, Lemmens VEPP, Creemers GJ et al (2011) Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy. Ann Oncol 22(10):2250\u20132256","journal-title":"Ann Oncol"},{"key":"1301_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00384-011-1303-8","volume":"27","author":"TC Chua","year":"2012","unstructured":"Chua TC, Liauw W, Morris DL (2012) Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome. Int J Colorectal Dis 27:381\u2013389","journal-title":"Int J Colorectal Dis"},{"key":"1301_CR22","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1245\/s10434-014-4297-y","volume":"22","author":"GA Simkens","year":"2015","unstructured":"Simkens GA, van Oudheusden TR, Luyer MD et al (2015) Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis. Ann Surg Oncol 22:2656\u20132662","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"1301_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3):176\u2013181","journal-title":"Semin Radiat Oncol"},{"key":"1301_CR24","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1245\/s10434-014-3713-7","volume":"21","author":"W Ceelen","year":"2014","unstructured":"Ceelen W, Van Nieuwenhove Y, Putte DV, Pattyn P (2014) Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (hipec) for colorectal carcinomatosis. Ann Surg Oncol 21:3023\u20133028","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"1301_CR25","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1245\/s10434-013-3442-3","volume":"21","author":"C Eveno","year":"2014","unstructured":"Eveno C, Passot G, Go\u00e9r\u00e9 D et al (2014) Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 21(6):1792\u20131800","journal-title":"Ann Surg Oncol"},{"key":"1301_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejca.2016.06.002","volume":"65","author":"V Kepenekian","year":"2016","unstructured":"Kepenekian V, Elias D, Passot G et al (2016) Diffuse malignant peritoneal mesothelioma: evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE database: Multi-Institutional Retrospective Study. Eur J Cancer 65:69\u201379","journal-title":"Eur J Cancer"},{"key":"1301_CR27","first-page":"118","volume":"6","author":"C-F Chen","year":"2008","unstructured":"Chen C-F, Huang C-J, Kang W-Y, Hsieh J-S (2008) Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin\/fluorouracil\/leucovorin (FOLFOX4). WJSO 6:118","journal-title":"WJSO"},{"issue":"4","key":"1301_CR28","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/annonc\/mdu031","volume":"25","author":"AM Kuijpers","year":"2014","unstructured":"Kuijpers AM, Mehta AM, Boot H et al (2014) Perioperative systemic chemotherapy in peritoneal carcinomatosis of lymph node positive colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Oncol 25(4):864\u2013869","journal-title":"Ann Oncol"},{"key":"1301_CR29","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/bjc.2013.118","volume":"108","author":"AI Phipps","year":"2013","unstructured":"Phipps AI, Buchanan DD, Makar KW et al (2013) KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers. Br J Cancer 108:1757\u20131764","journal-title":"Br J Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-018-1301-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-018-1301-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-018-1301-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T19:20:13Z","timestamp":1559676013000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-018-1301-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1301"],"URL":"https:\/\/doi.org\/10.1007\/s10147-018-1301-8","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,5]]},"assertion":[{"value":"14 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflict of interest or receive any funding for research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}